Minori Mizoguchi
- Clinical Biochemistry top 5%
- Advanced Glycation End Products research 3
-
- Cardiovascular Disease and Adiposity 2
- Cardiovascular Health and Disease Prevention 2
- Lipid metabolism and disorders 1
-
- Cerebrovascular and Carotid Artery Diseases 2
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 1
-
- Adipokines, Inflammation, and Metabolic Diseases 2
-
- Nitric Oxide and Endothelin Effects 1
- Co-authors
- Tsutomu ImaizumiNobuhiro TaharaMasatoshi IshibashiNaofumi HayabuchiHayato KaidaYoshikazu NittaNorihiro KodamaSho‐ichi Yamagishi
- Cited by
- Clinical BiochemistryCardiology and Cardiovascular MedicinePulmonary and Respiratory Medicine
- Journals
- Journal of the American College of Cardiology (1 paper)The Journal of Clinical Endocrinology & Metabolism (1 paper)Diabetes Care (1 paper)
- Partner nations
- JapanUnited StatesGermany
In The Last Decade
Minori Mizoguchi
11 papers receiving 812 citations
Peers
Comparison fields: 5 of 74
- Clinical Biochemistry 152
- Cardiology and Cardiovascular Medicine 291
- Pulmonary and Respiratory Medicine 356
- Endocrinology, Diabetes and Metabolism 162
- Radiology, Nuclear Medicine and Imaging 188
Countries citing papers authored by Minori Mizoguchi
This map shows the geographic impact of Minori Mizoguchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Minori Mizoguchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Minori Mizoguchi more than expected).
Fields of papers citing papers by Minori Mizoguchi
This network shows the impact of papers produced by Minori Mizoguchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Minori Mizoguchi. The network helps show where Minori Mizoguchi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Minori Mizoguchi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 47 | |
| 2 | 2013 | 39 | |
| 3 | 2013 | 117 | |
| 4 | 2013 | 10 | |
| 5 | 2012 | 70 | |
| 6 | 2011 | 41 | |
| 7 | 2011 | 102 | |
| 8 | 2010 | 100 | |
| 9 | 2010 | 126 | |
| 10 | 2008 | 8 | |
| 11 | 2007 | 163 |
About Minori Mizoguchi
Minori Mizoguchi is a scholar working on Clinical Biochemistry, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine, having authored 11 papers that have together received 823 indexed citations. Recurring topics across this work include Advanced Glycation End Products research (3 papers), Adipokines, Inflammation, and Metabolic Diseases (2 papers), Cardiovascular Disease and Adiposity (2 papers), Cerebrovascular and Carotid Artery Diseases (2 papers), Cardiovascular Health and Disease Prevention (2 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (1 paper), Lipid metabolism and disorders (1 paper) and Nitric Oxide and Endothelin Effects (1 paper). The work is most often cited by research in Clinical Biochemistry (152 citations), Cardiology and Cardiovascular Medicine (291 citations) and Pulmonary and Respiratory Medicine (356 citations). Minori Mizoguchi has collaborated with scholars based in Japan, United States and Germany. Frequent co-authors include Tsutomu Imaizumi, Nobuhiro Tahara, Masatoshi Ishibashi, Naofumi Hayabuchi, Hayato Kaida, Yoshikazu Nitta, Norihiro Kodama, Sho‐ichi Yamagishi, Atsuko Tahara and Kenkichi Baba. Their work appears in journals such as Journal of the American College of Cardiology, The Journal of Clinical Endocrinology & Metabolism and Diabetes Care.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.